<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_Hong_Kong_HKUST_characterization_ef1a"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:Hong_Kong_HKUST/characterization/ef1a">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:Hong_Kong_HKUST/characterization/ef1a&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:Hong_Kong_HKUST/characterization/ef1a&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:Hong_Kong_HKUST/characterization/ef1a&amp;action=history">History               </A></LI><LI style="color:white;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:Hong_Kong_HKUST/characterization/ef1a" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:Hong Kong HKUST/characterization/ef1a</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2013.igem.org</H3><P id="back-top" style="display:none;"><A href="#top"><SPAN>BACK TO TOP</SPAN></A></P><DIV class="menu"><UL class="first"><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST">Home</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/team">Team</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/members">Members</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/advisors">Advisors</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/instructors">Instructors</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/attribution">Attribution</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/acknowledge">Acknowledgement</A></LI></UL><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/Project">Project</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/abstract">Abstract</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/modules">Modules Description</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/data">Data Page</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/Parts">Parts</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/characterization">Characterization</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/results">Result</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/future">Future Work</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/Wetlab">Wetlab</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/notebook">Notebook</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/protocols">Protocols</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/safety">Safety</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/achievement">Achievement</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/medals">Medal Requirements</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/prizes">Prizes</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp">Human Practice</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/cp">Country Profile</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/blog">Blog</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/interview">Interviews</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/article/genet">Article</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/video">Videos</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/presentation">Presentations</A></LI></DIV><DIV class="row"><DIV class="two columns"><UL class="side-nav"><H6><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/characterization">Characterization</A></H6><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/characterization/mls">Mitochondrial Leader Sequence</A></LI><LI><A href="https://2013.igem.org/Team:Hong_Kong_HKUST/characterization/cmv">CMV Promoter</A></LI><LI>
					EF-1alpha Promoter</LI><LI><A href="#introduction">Introduction</A></LI><LI><A href="#method">Method</A></LI><LI><A href="#cp">Characterization Procedure</A></LI><LI><A href="#ct">Cell Culture and Transfection</A></LI><LI><A href="#result">Result</A></LI><LI><A href="#conclusion">Conclusion</A></LI><LI><A href="#reference">Reference</A></LI></UL></DIV><DIV class="ten columns team-bios-container"><DIV class="row" id="ugd-members"><DIV class="twelve columns"><H2 class="centered">EF-1alpha Promoter</H2></DIV></DIV><DIV class="row"><DIV class="nine columns"><H3>Introduction</H3><P>The constitutive human Elongation Factor-1alpha (EF-1alpha) Promoter regulates gene expression in mammalian cells. It is known that the CMV promoter is commonly used for constitutive expression, and here we introduce EF-1alpha promoter as an alternative mammalian promoter, which works in a wide range of cell types. The origin of this part is from <I>Homo sapiens</I> chromosome 6 genomic contig, GRCh37. p13.</P><P>In our characterization, the sequence of EF-1alpha Promoter was assembled in front of a GFP reporter (<A href="http://parts.igem.org/Part:BBa_K648013">BBa_K648013</A>) and hGH polyA terminator (<A href="http://parts.igem.org/Part:BBa_K404108">BBa_K404108</A>) using Freiburg’s RFC25 format. The EF-1alpha promoter-GFP was then transfected into HEK293FT cells and in vivo green fluorescence signal was observed under fluorescence microscope. The positive control was iDUET101a plasmid (<A href="http://www.addgene.org/17629/">Addgene Plasmid Number 17629</A>) that contains EGFP reporter driven by an EF-1alpha promoter. A negative control was made by GFP generator that does not contain the EF-1alpha promoter. As a side by side comparison, a CMV promoter driven GFP reporter was also transfected, though a quantitative comparison between the two was not conducted in our characterization.

<A href="https://2013.igem.org/Team:Hong_Kong_HKUST/protocols">Detailed protocols</A> for our characterization work can be accessed via the link.</P></DIV></DIV><DIV class="row"><DIV class="nine columns"><H3>Characterization Procedure</H3><P>1.    Build:</P><P>-       EF-1alpha characterization construct: EF-1alpha promoter – Green Fluorescence Protein (GFP) – hGH polyadenylation sequence (hGH pA) - pSB1C3
(BBa_K1119010 – BBa_K648013 – BBa_K404108 – pSB1C3)</P><P>-       CMV comparison construct: CMV promoter – Green Fluorescence Protein (GFP) – hGH polyadenylation sequence (hGH pA) - pSB1C3
(BBa_K1119006 – BBa_K648013 – BBa_K404108 – pSB1C3)</P><P>-       Negative control construct: GFP – hGH pA - pSB1C3
(BBa_K648013 – BBa_K404108 – pSB1C3)</P><P>2.    Prepare iDUET101a (Addgene) in which EF-1alpha promoter was cloned from. This plasmid contains EF-1alpha promoter and EGFP reporter. We have transfected this plasmid for positive control for EF-1alpha characterization.</P><P>3.    Culture HEK293FT cell line (see below)</P><P>4.    Transfect EF-1alpha characterization construct, CMV construct, negative control and positive control plasmids in HEK293FT cell line.</P><P>5.    Observe GFP signal under fluorescence microscope
</P></DIV></DIV><DIV class="row"><DIV class="nine columns"><H3>Cell Culture and Transfection</H3><P>
We cultured HEK 293FT cells following American Type Culture Collection’s standard procedure, except that we used DMEM with 10% FBS and 1% penicillin/streptomycin in our culture medium. For transfection, we  followed the manufacturer’s protocol of LipofectamineTM 2000 (Invitrogen) and used serum-free and antibiotics-free DMEM to form the DNA-lipofectamine complex. 
</P></DIV></DIV><DIV class="row"><DIV class="nine columns"><H3>Result</H3><P><B>Figure 1: GFP signal of EF-1alpha observed.</B> HEK293FT cells were transfected with iDUET101a (positive control), pEF-1alpha-GFP, pCMV-GFP (alternative mammalian constitutive promoter), and GFP without promoter. Cells transfected with pEF-1alpha-GFP showed weaker green signal compared to those with iDUET101a and pCMV-GFP. This result agreed with the result reported by Qin et al., that the EF-1alpha promoter gives weaker activity than CMV promoter in HEK293T cells. Our negative control, GFP without promoter did not give any GFP signal. Scale bar = 0.1mm</P><P><I>At the time of regional jamboree, no GFP signal could be observed in cells transfected with GFP reporter driven by EF-1alpha promoter. Originally, we thought that the sequence of EF-1alpha promoter cloned from iDUET101a contained the full functional promoter region annotated in pBudCE4.1 (Invitrogen). We believed that EF-1alpha did trigger transcription but failed to translate the GFP coding sequence due to insufficient 5’ untranslated region (UTR). After the regional jamboree, the promoter was re-cloned with additional 3' sequences after the identified TATA box to allow a longer 5’ untranslated region before the GFP coding DNA sequence. From the the results above, we believed that translation of GFP is successful this time.</I></P></DIV></DIV><DIV class="row"><DIV class="nine columns"><H3>Conclusion</H3><P>The EF-1alpha promoter is fully functional and has a weaker transcriptional strength than the CMV promoter in HEK293FT cells.</P></DIV></DIV><DIV class="row"><DIV class="nine columns"><H3>Reference</H3><P>Qin, Jane Yuxia, Li Zhang, et al. &quot;Systematic Comparison of Constitutive Promoters and the Doxycycline-Inducible Promoter.&quot; PLoS ONE. 5.5 (2010) <HTTP:>.</HTTP:></P><P>Zhou, B. Y., Ye, Z., Chen, G., Gao, Z. P., Zhang, Y. A., &amp; Cheng, L. (2007). Inducible and reversible transgene expression in human stem cells after efficient and stable gene transfer. Stem Cells, 25(3), 779-789. doi:10.1634/stemcells.2006-0128 </P></DIV></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2013.igem.org/Team:Hong_Kong_HKUST/characterization/ef1a">http://2013.igem.org/Team:Hong_Kong_HKUST/characterization/ef1a</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:Hong_Kong_HKUST/characterization/ef1a" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:Hong_Kong_HKUST/characterization/ef1a" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:Hong_Kong_HKUST/characterization/ef1a&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:Hong_Kong_HKUST/characterization/ef1a&amp;oldid=361061" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2013.igem.org:Privacy_policy" title="2013.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2013.igem.org:General_disclaimer" title="2013.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></DIV></DIV></BODY></HTML>